<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://priyalifescience.com/article/abbvie-disco-bispecific-cancer-deal-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-22T17:00:02+00:00</news:publication_date>
      <news:title>AbbVie Signs $2.5bn Bispecific Cancer Deal with Disco</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/amylyx-avexitide-lucidity-phase-3-post-bariatric-hypoglycemia-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-22T15:00:02+00:00</news:publication_date>
      <news:title>Amylyx Avexitide Cuts Post-Bariatric Hypoglycaemia by 55%</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/dexcom-opens-athenry-plant-galway-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-22T08:30:02+00:00</news:publication_date>
      <news:title>Dexcom Opens €300m Athenry Plant, Aiming for 1,000 Jobs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/sellas-regal-phase-3-galinpepimut-s-aml-overall-survival-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T17:00:01+00:00</news:publication_date>
      <news:title>SELLAS Says AML Vaccine GPS Extended Survival in Phase 3</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/weight-loss-drugs-uk-grocery-spending-worldpanel-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T15:00:02+00:00</news:publication_date>
      <news:title>Weight-Loss Drugs Cut UK Grocery Spending by Over £1bn</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/fda-approves-gsk-nelkarmi-neladalkib-alk-lung-cancer-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T13:00:02+00:00</news:publication_date>
      <news:title>FDA Approves GSK's Nelkarmi for ALK-Positive Lung Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/fda-approves-sanofi-infilbray-gaucher-disease-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T11:00:03+00:00</news:publication_date>
      <news:title>FDA Approves Sanofi's Infilbray for Type 3 Gaucher Disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/regeneron-ireland-profits-2025-accounts</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T08:30:02+00:00</news:publication_date>
      <news:title>Regeneron Ireland Profits Rise 20% to $4.91bn in 2025</news:title>
    </news:news>
  </url>
</urlset>